Mucoadhesive drug delivery system with enhanced permeability capacity for intravesical therapy
Carregando...
Data
Data de publicação
2023
Orientador
Título da Revista
ISSN da Revista
Título do Volume
É parte de
É parte de
É parte de
É parte de
LATIN-AMERICAN CONGRESS OF ARTIFICIAL ORGANS AND BIOMATERIALS, 12th
Exportar
Resumo
Introduction and objective: Bladder cancer (BC) represents 3% of the new diagnosis of cancer. 70% of the
patients present the non-muscle-invasive type of the disease [1]. This type of BC is usually treated by the
transurethral resection of the visible tumor, followed by intravesical inmuno- or chemotherapy. The
instillation of chemotherapy into the bladder is not totally efficient as it faces limitations such as short
residence time and permeability restrictions of the bladder mucosa [2]. Thus, the main objective of this work
was to develop drug delivery formulations for intravesical chemotherapy that enhance its residence time and
permeation capacity. Methodology: Carboxymethylcellulose (CMC) and polyvinyl alcohol (PVA) polymers
were used to prepare a physical hydrogel with mucoadhesive properties. Papain, a thiol proteolytic enzyme,
was added to the formulations as a permeation enhancer. The mucoadhesive capacity of the formulation was
evaluated by its interaction with mucin, bioadhesion strength and retention on bladder urothelium. Ex-vivo
drug permeation was also elucidated using Franz cells to observe the papain effect.
Results and discussion: The CMC + PVA formulations showed positive bioadhesion components, confirming
their interaction with the urothelium. The significant decrease of ɳb in the formulation containing enzyme
suggests that papain was cleaving the glycoproteins present in the mucin. On bioadhesion strength assays,
the prepared formulations required a slightly higher detachment force than the control. In terms of work of
adhesion, all formulations had values higher than those recorded for the control (p < 0.05), confirming that
there were mucoadhesive interactions between the bladder tissue and the gels. Hydrogel retention assay
revealed that the formulations had higher bioadhesion capacity than the control (FITC solution), especially
after the third wash (15 mL). By drug permeation analysis, it was possible to observe that the lag time
decreased for CMC + PVA hydrogels with and without papain in comparison to the control. At the timepoint
of 2 h, the formulation containing papain presented the highest capacity of permeation.
Conclusions: The biocompatible hydrogel containing papain as a permeability enhancer was an innovative
approach for BC treatment to address the poor permeation of the tissue and short residence time. The
formulation developed in this work could represent a very notable improvement in clinical practice, ensuring
a longer retention time of the formulation in the bladder tissue, with a more sustained release of the drug
and greater permeation capacity.
Como referenciar
LIMA, CAROLINE S.A. de; RIAL-HERMIDA, M.I.; FERREIRA, ARYEL H.; FREITAS, LUCAS F. de; VARCA, GUSTAVA H.C.; ALVAREZ-LORENZO, CARMEN; LUGAO, ADEMAR B. Mucoadhesive drug delivery system with enhanced permeability capacity for intravesical therapy. In: LATIN-AMERICAN CONGRESS OF ARTIFICIAL ORGANS AND BIOMATERIALS, 12th, December 12-15, 2023, Mar del Plata, Argentina. Abstract... p. 171-171. Disponível em: https://repositorio.ipen.br/handle/123456789/47938. Acesso em: 27 Mar 2026.
Esta referência é gerada automaticamente de acordo com as normas do estilo IPEN/SP (ABNT NBR 6023) e recomenda-se uma verificação final e ajustes caso necessário.